Standford-StartX Fund has taken part in a $10m series B round for Prescient Surgical, which was led by Baxter Ventures.

US-based medical device developer Prescient Surgical raised $10m yesterday in a series B round that featured Stanford University’s Standford-StartX Fund.
Baxter Ventures, the strategic investment unit of medical products maker Baxter International, led the round, while Summation Health Ventures, the venture capital fund formed by healthcare systems Cedars-Sinai and MemorialCare and private equity firm CWC HealthTech Advisors also participated.
Prescient Surgical designs and develops tools and technologies to combat the sources of surgical site infection. Its flagship product,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?